fda compounding semaglutide crackdown news today 2025 National Hispanic Medical Association | After compounded GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and The Food and Drug Administration's

22% of those who were told by a doctor that they are overweight or obese report having used GLP-1 medications

9 This switch isnt required for Wegovy

Others say their periods, which had been irregular for years, suddenly arrive like clockwork

Obesity is the biggest risk factor for Type 2 diabetes, and substantial weight loss can help in reversal and remission of the disease, as well as reduced risk for conditions like high blood pressure, dyslipidemia, heart disease, and stroke

Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium

Pregnancy and lactation: There is insufficient safety data regarding use during pregnancy or breastfeeding